94 results on '"Lazarevic I"'
Search Results
2. Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe
- Author
-
Ozaras, R., Corti, G., Ruta, S., Lacombe, K., Mondelli, M.U., Irwing, W.L., Puoti, M., Khalighi, A., Santos, M.L., Harxhi, A., Lazarevic, I., Soriano, V., Gervain, J., Leblebicioglu, H., Salmon, D., and Arends, J.E.
- Published
- 2015
- Full Text
- View/download PDF
3. Reshaping Clinical Trial Data Collection Process to Use the Advantages of the Web-Based Electronic Data Collection
- Author
-
Pavlovic, Ivan, Lazarevic, I., Jarm, Tomaz, editor, Kramar, Peter, editor, and Zupanic, Anze, editor
- Published
- 2007
- Full Text
- View/download PDF
4. AB1464 THE ROLE OF EPSTEIN-BARR VIRUS ACTIVITY IN RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PATIENTS
- Author
-
Banko, A., primary, Miljanovic, D., additional, Jeremic, I., additional, Basarić, M., additional, Grk, M., additional, Lazarevic, I., additional, Miskovic, R., additional, and Cirkovic, A., additional
- Published
- 2022
- Full Text
- View/download PDF
5. Distribution of HBV genotypes, subgenotypes and HBsAg subtypes among chronically infected patients in Serbia
- Author
-
Lazarevic, I., Cupic, M., Delic, D., Svirtlih, N. S., Simonovic, J., and Jovanovic, T.
- Published
- 2007
- Full Text
- View/download PDF
6. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
- Author
-
Colagrossi, L. Hermans, L.E. Salpini, R. Di Carlo, D. Pas, S.D. Alvarez, M. Ben-Ari, Z. Boland, G. Bruzzone, B. Coppola, N. Seguin-Devaux, C. Dyda, T. Garcia, F. Kaiser, R. Köse, S. Krarup, H. Lazarevic, I. Lunar, M.M. Maylin, S. Micheli, V. Mor, O. Paraschiv, S. Paraskevis, D. Poljak, M. Puchhammer-Stöckl, E. Simon, F. Stanojevic, M. Stene-Johansen, K. Tihic, N. Trimoulet, P. Verheyen, J. Vince, A. Lepej, S.Z. Weis, N. Yalcinkaya, T. Boucher, C.A.B. Wensing, A.M.J. Perno, C.F. Svicher, V. HEPVIR working group of the European Society for translational antiviral research (ESAR)
- Abstract
Background: HBsAg immune-escape mutations can favor HBV-transmission also in vaccinated individuals, promote immunosuppression-driven HBV-reactivation, and increase fitness of drug-resistant strains. Stop-codons can enhance HBV oncogenic-properties. Furthermore, as a consequence of the overlapping structure of HBV genome, some immune-escape mutations or stop-codons in HBsAg can derive from drug-resistance mutations in RT. This study is aimed at gaining insight in prevalence and characteristics of immune-associated escape mutations, and stop-codons in HBsAg in chronically HBV-infected patients experiencing nucleos(t)ide analogues (NA) in Europe. Methods: This study analyzed 828 chronically HBV-infected European patients exposed to ≥ 1 NA, with detectable HBV-DNA and with an available HBsAg-sequence. The immune-associated escape mutations and the NA-induced immune-escape mutations sI195M, sI196S, and sE164D (resulting from drug-resistance mutation rtM204 V, rtM204I, and rtV173L) were retrieved from literature and examined. Mutations were defined as an aminoacid substitution with respect to a genotype A or D reference sequence. Results: At least one immune-associated escape mutation was detected in 22.1% of patients with rising temporal-trend. By multivariable-analysis, genotype-D correlated with higher selection of ≥ 1 immune-associated escape mutation (OR[95%CI]:2.20[1.32-3.67], P = 0.002). In genotype-D, the presence of ≥ 1 immune-associated escape mutations was significantly higher in drug-exposed patients with drug-resistant strains than with wild-type virus (29.5% vs 20.3% P = 0.012). Result confirmed by analysing drug-naïve patients (29.5% vs 21.2%, P = 0.032). Strong correlation was observed between sP120T and rtM204I/V (P < 0.001), and their co-presence determined an increased HBV-DNA. At least one NA-induced immune-escape mutation occurred in 28.6% of patients, and their selection correlated with genotype-A (OR[95%CI]:2.03[1.32-3.10],P = 0.001). Finally, stop-codons are present in 8.4% of patients also at HBsAg-positions 172 and 182, described to enhance viral oncogenic-properties. Conclusions: Immune-escape mutations and stop-codons develop in a large fraction of NA-exposed patients from Europe. This may represent a potential threat for horizontal and vertical HBV transmission also to vaccinated persons, and fuel drug-resistance emergence. © 2018 The Author(s).
- Published
- 2018
7. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
- Author
-
Colagrossi, L. (Luna), Hermans, L.E. (Lucas Etienne), Salpini, R. (Romina), Di Carlo, D., Pas, S.D. (Suzan), Alvarez, M.R. (Marta), Ben Ari, Z. (Ziv), Boland, G.J. (Greet), Bruzzone, B. (Bianca), Coppola, N. (Nicola), Seguin-Devaux, C., Dyda, T. (Tomasz), Garcia, F. (Federico), Kaiser, R. (Rolf), Köse, S. (Sukran), Krarup, H.B. (H.), Lazarevic, I. (Ivana), Lunar, M.M. (Maja M.), Maylin, S. (Sarah), Micheli, V. (Valeria), Mor, O. (Orna), Paraschiv, C. (Corina), Paraskevis, D. (Dimitrios), Poljak, M. (Mario), Puchhammer-Stöckl, E. (Elisabeth), Simon, F. (François), Stanojevic, M. (Maja), Stene-Johansen, K. (Kathrine), Tihic, N. (Nijaz), Trimoulet, P. (Pascale), Verheyen, J. (Jens), Vince, A. (Adriana), Lepej, S.Z. (Snjezana), Weis, N. (Nina), Yalcinkaya, T. (Tülay), Boucher, C.A.B. (Charles), Wensing, A. (Amj), Perno, C.F. (Carlo), Svicher, V. (Valentina), Colagrossi, L. (Luna), Hermans, L.E. (Lucas Etienne), Salpini, R. (Romina), Di Carlo, D., Pas, S.D. (Suzan), Alvarez, M.R. (Marta), Ben Ari, Z. (Ziv), Boland, G.J. (Greet), Bruzzone, B. (Bianca), Coppola, N. (Nicola), Seguin-Devaux, C., Dyda, T. (Tomasz), Garcia, F. (Federico), Kaiser, R. (Rolf), Köse, S. (Sukran), Krarup, H.B. (H.), Lazarevic, I. (Ivana), Lunar, M.M. (Maja M.), Maylin, S. (Sarah), Micheli, V. (Valeria), Mor, O. (Orna), Paraschiv, C. (Corina), Paraskevis, D. (Dimitrios), Poljak, M. (Mario), Puchhammer-Stöckl, E. (Elisabeth), Simon, F. (François), Stanojevic, M. (Maja), Stene-Johansen, K. (Kathrine), Tihic, N. (Nijaz), Trimoulet, P. (Pascale), Verheyen, J. (Jens), Vince, A. (Adriana), Lepej, S.Z. (Snjezana), Weis, N. (Nina), Yalcinkaya, T. (Tülay), Boucher, C.A.B. (Charles), Wensing, A. (Amj), Perno, C.F. (Carlo), and Svicher, V. (Valentina)
- Abstract
Background: HBsAg immune-escape mutations can favor HBV-transmission also in vaccinated individuals, promote immunosuppression-driven HBV-reactivation, and increase fitness of drug-resistant strains. Stop-codons can enhance HBV oncogenic-properties. Furthermore, as a consequence of the overlapping structure of HBV genome, some immune-escape mutations or stop-codons in HBsAg can derive from drug-resistance mutations in RT. This study is aimed at gaining insight in prevalence and characteristics of immune-associated escape mutations, and stop-codons in HBsAg in chronically HBV-infected patients experiencing nucleos(t)ide analogues (NA) in Europe. Methods: This study analyzed 828 chronically HBV-infected European patients exposed to ≥ 1 NA, with detectable HBV-DNA and with an available HBsAg-sequence. The immune-associated escape mutations and the NA-induced immune-escape mutations sI195M, sI196S, and sE164D (resulting from drug-resistance mutation rtM204 V, rtM204I, and rtV173L) were retrieved from literature and examined. Mutations were defined as an aminoacid substitution with respect to a genotype A or D reference sequence. Results: At least one immune-associated escape mutation was detected in 22.1% of patients with rising temporal-trend. By multivariable-analysis, genotype-D correlated with higher selection of ≥ 1 immune-associated escape mutation (OR[95%CI]:2.20[1.32-3.67], P = 0.002). In genotype-D, the presence of ≥ 1 immune-associated escape mutations was significantly higher in drug-exposed patients with drug-resistant strains than with wild-type virus (29.5% vs 20.3% P = 0.012). Result confirmed by anal
- Published
- 2018
- Full Text
- View/download PDF
8. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
- Author
-
Colagrossi, L, Hermans, Lucas, Salpini, R, Di Carlo, D, Pas, Suzan, Alvarez, M, Ben-Ari, Z, Boland, G, Bruzzone, B, Coppola, N, Seguin-Devaux, C, Dyda, T, Garcia, F, Kaiser, R, Kose, S, Krarup, H, Lazarevic, I, Lunar, MM, Maylin, S, Micheli, V, Mor, O, Paraschiv, S, Paraskevis, D, Poljak, M, Puchhammer-Stockl, E, Simon, F, Stanojevic, M, Stene-Johansen, K, Tihic, N, Trimoulet, P, Verheyen, J, Vince, A, Lepej, SZ, Weis, N, Yalcinkaya, T, Boucher, Charles, Wensing, AMJ, Perno, CF, Svicher, V, Colagrossi, L, Hermans, Lucas, Salpini, R, Di Carlo, D, Pas, Suzan, Alvarez, M, Ben-Ari, Z, Boland, G, Bruzzone, B, Coppola, N, Seguin-Devaux, C, Dyda, T, Garcia, F, Kaiser, R, Kose, S, Krarup, H, Lazarevic, I, Lunar, MM, Maylin, S, Micheli, V, Mor, O, Paraschiv, S, Paraskevis, D, Poljak, M, Puchhammer-Stockl, E, Simon, F, Stanojevic, M, Stene-Johansen, K, Tihic, N, Trimoulet, P, Verheyen, J, Vince, A, Lepej, SZ, Weis, N, Yalcinkaya, T, Boucher, Charles, Wensing, AMJ, Perno, CF, and Svicher, V
- Published
- 2018
9. ON THE APPROXIMATION OF THE LOGARITHMIC FUNCTION BY SEQUENCES OF ALGEBRAIC FUNCTIONS (II) / O APROKSIMACLJI LOGARITAMSKE FUNKCIJE NIZOVIMA ALGEBARSKIH FUNKCIJA (II)
- Author
-
Lazarević, I. and Lupaş, A.
- Published
- 1982
10. NEKE NEJEDNAKOSTI SA HIPERBOLIČKIM FUNKCIJAMA / CERTAINES INÉGALITÉS OÙ INTERVIENNENT LES FONCTIONS HIPÉRBOLIQUES
- Author
-
Lazarević, I.
- Published
- 1966
11. IMMUNE-ESCAPE MUTATIONS AND STOP-CODONS IN HBSAG CIRCULATES IN A RELEVANT PROPORTION OF PATIENTS WITH CHRONIC HBV INFECTION EXPOSED TO ANTI-HBV DRUGS IN EUROPE: IMPLICATIONS FOR HBV TRANSMISSION IN THE SETTING OF VACCINATION AND DISEASE PROGRESSION
- Author
-
Colagrossi, L. Hermans, L. E. Salpini, R. Pas, S. D. and Alvarez, M. Ben Ari, Z. Boland, G. Bruzzone, B. Coppola, N. Seguin-Devaux, C. Dyda, T. Garcia, F. Kaiser, R. and Kose, S. Krarup, H. Lazarevic, I. Lunar, M. M. Maylin, S. Micheli, V. Mor, O. Paraschiv, S. Paraskevis, D. and Poljak, M. Puchhammer-Stoeckl, E. Simon, F. Stanojevic, M. and Stene-Johansen, K. Tihic, N. Trimoulet, P. Verheyen, J. and Vince, A. Weis, N. Yalcinkaya, T. Lepej, S. Z. and Boucher, C. A. Wensing, A. M. Perno, C. F. Svicher, V. and European Soc Translational
- Published
- 2016
12. Combined analysis of the prevalence of drug-resistant Hepatitis B virus in antiviral therapy-experienced patients in Europe (CAPRE)
- Author
-
Hermans, L.E. Svicher, V. Pas, S.D. Salpini, R. Alvarez, M. Ben Ari, Z. Boland, G. Bruzzone, B. Coppola, N. Seguin-Devaux, C. Dyda, T. Garcia, F. Kaiser, R. Köse, S. Krarup, H. Lazarevic, I. Lunar, M.M. Maylin, S. Micheli, V. Mor, O. Paraschiv, S. Paraskevis, D. Poljak, M. Puchhammer-Stöckl, E. Simon, F. Stanojevic, M. Stene-Johansen, K. Tihic, N. Trimoulet, P. Verheyen, J. Vince, A. Weis, N. Yalcinkaya, T. Lepej, S.Z. Perno, C. Boucher, C.A.B. Wensing, A.M.J.
- Abstract
Background European guidelines recommend treatment of chronic hepatitis B virus infection (CHB) with the nucleos(t)ide analogs (NAs) entecavir or tenofovir. However, many European CHB patients have been exposed to other NAs, which are associated with therapy failure and resistance. The CAPRE study was performed to gain insight in prevalence and characteristics of NA resistance in Europe. Methods A survey was performed on genotypic resistance testing results acquired during routine monitoring of CHB patients with detectable serum hepatitis B virus DNA in European tertiary referral centers. Results Data from 1568 patients were included. The majority (73.8%) were exposed to lamivudine monotherapy. Drug-resistant strains were detected in 52.7%. The most frequently encountered primary mutation was M204V/I (48.7%), followed by A181T/V (3.8%) and N236T (2.6%). In patients exposed to entecavir (n = 102), full resistance was present in 35.3%. Independent risk factors for resistance were age, viral load, and lamivudine exposure (P
- Published
- 2016
13. IMMUNE-ESCAPE MUTATIONS AND STOP-CODONS IN HBSAG CIRCULATES IN A RELEVANT PROPORTION OF PATIENTS WITH CHRONIC HBV INFECTION EXPOSED TO ANTI-HBV DRUGS IN EUROPE: IMPLICATIONS FOR HBV TRANSMISSION IN THE SETTING OF VACCINATION AND DISEASE PROGRESSION
- Author
-
Colagrossi, L., Hermans, L. E., Salpini, R., Pas, S. D., Alvarez, M., Ben Ari, Z., Boland, G., Bruzzone, B., Coppola, N., Seguin-Devaux, C., Dyda, T., Garcia, F., Kaiser, R., Kose, S., Krarup, H., Lazarevic, I., Lunar, M. M., Maylin, S., Micheli, V., Mor, O., Paraschiv, S., Paraskevis, D., Poljak, M., Puchhammer-Stoeckl, E., Simon, F., Stanojevic, M., Stene-Johansen, K., Tihic, N., Trimoulet, P., Verheyen, J., Vince, A., Weis, N., Yalcinkaya, T., Lepej, S. Z., Boucher, C. A., Wensing, A. M., Perno, C. F., Svicher, V., Colagrossi, L., Hermans, L. E., Salpini, R., Pas, S. D., Alvarez, M., Ben Ari, Z., Boland, G., Bruzzone, B., Coppola, N., Seguin-Devaux, C., Dyda, T., Garcia, F., Kaiser, R., Kose, S., Krarup, H., Lazarevic, I., Lunar, M. M., Maylin, S., Micheli, V., Mor, O., Paraschiv, S., Paraskevis, D., Poljak, M., Puchhammer-Stoeckl, E., Simon, F., Stanojevic, M., Stene-Johansen, K., Tihic, N., Trimoulet, P., Verheyen, J., Vince, A., Weis, N., Yalcinkaya, T., Lepej, S. Z., Boucher, C. A., Wensing, A. M., Perno, C. F., and Svicher, V.
- Published
- 2016
14. Immune-Escape Mutations and Stop-Codons in HBsAg Circulates in a Relevant Proportion of Patients with Chronic HBV Infection Exposed to Anti-HBV Drugs in Europe: Implications for HBV Transmission in the Setting of Vaccination and Disease Progression
- Author
-
Colagrossi, L., primary, Hermans, L.E., additional, Salpini, R., additional, Pas, S.D., additional, Alvarez, M., additional, Ben Ari, Z., additional, Boland, G., additional, Bruzzone, B., additional, Coppola, N., additional, Seguin-Devaux, C., additional, Dyda, T., additional, Garcia, F., additional, Kaiser, R., additional, Köse, S., additional, Krarup, H., additional, Lazarevic, I., additional, Lunar, M.M., additional, Maylin, S., additional, Micheli, V., additional, Mor, O., additional, Paraschiv, S., additional, Paraskevis, D., additional, Poljak, M., additional, Puchhammer-Stöckl, E., additional, Simon, F., additional, Stanojevic, M., additional, Stene-Johansen, K., additional, Tihic, N., additional, Trimoulet, P., additional, Verheyen, J., additional, Vince, A., additional, Weis, N., additional, Yalcinkaya, T., additional, Lepej, S.Z., additional, Boucher, C.A., additional, Wensing, A.M., additional, Perno, C.F., additional, and Svicher, V., additional
- Published
- 2016
- Full Text
- View/download PDF
15. Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe
- Author
-
Ozaras, R, Corti, G, Ruta, S, Lacombe, K, Mondelli, M, Irwing, W, Puoti, M, Khalighi, A, Santos, M, Harxhi, A, Lazarevic, I, Soriano, V, Gervain, J, Leblebicioglu, H, Salmon, D, Arends, J, Mondelli, MU, Irwing, WL, Santos, ML, Arends, JE, Ozaras, R, Corti, G, Ruta, S, Lacombe, K, Mondelli, M, Irwing, W, Puoti, M, Khalighi, A, Santos, M, Harxhi, A, Lazarevic, I, Soriano, V, Gervain, J, Leblebicioglu, H, Salmon, D, Arends, J, Mondelli, MU, Irwing, WL, Santos, ML, and Arends, JE
- Abstract
The prevalence and management of chronic hepatitis B virus (HBV) infection differ among European countries. The availability and reimbursement of diagnostics and drugs may also vary, determining distinct treatment outcomes. Herein, we analyse differences in medical facilities for the care of patients with chronic HBV infection across Europe. A survey was sent to the members of the ESCMID Study Group for Viral Hepatitis, all of whom are experts in chronic HBV infection management. The comprehensive survey asked questions regarding hepatitis B surface antigen (HBsAg) prevalence, the availability of diagnostics and drugs marketed, and distinct clinical practice behaviours in the management of chronic HBV infection. World Bank data were used to assess the economic status of the countries. With 16 expert physicians responding (69%), the HBsAg prevalence rates were <1% in France, Hungary, Italy, The Netherlands, Portugal, Spain, and the UK, intermediate (1-5%) in Turkey, Romania, and Serbia, and high (>5%) in Albania and Iran. Regarding the availability and reimbursement of HBV diagnostics (HBV DNA and liver stiffness measurement), HBV drugs (interferon, lamivudine, tenofovir, and entecavir), HBV prophylaxis, and duration of HBeAg-positive and HBeAg-negative HBV infection, the majority of high-income and middle-income countries had no restrictions; Albania, Iran and Serbia had several restrictions in diagnostics and HBV drugs. The countries in the high-income group were also the ones with no restrictions in medical facilities, whereas the upper-middle-income countries had some restrictions. The prevalence of chronic HBV infection is much higher in southern and eastern than in western European countries. Despite the availability of European guidelines, policies for diagnostics and treatment vary significantly across European countries.
- Published
- 2015
16. Reshaping Clinical Trial Data Collection Process to Use the Advantages of the Web-Based Electronic Data Collection
- Author
-
Pavlovic, Ivan, primary and Lazarevic, I., additional
- Full Text
- View/download PDF
17. THU-136 - Immune-Escape Mutations and Stop-Codons in HBsAg Circulates in a Relevant Proportion of Patients with Chronic HBV Infection Exposed to Anti-HBV Drugs in Europe: Implications for HBV Transmission in the Setting of Vaccination and Disease Progression
- Author
-
Colagrossi, L., Hermans, L.E., Salpini, R., Pas, S.D., Alvarez, M., Ben Ari, Z., Boland, G., Bruzzone, B., Coppola, N., Seguin-Devaux, C., Dyda, T., Garcia, F., Kaiser, R., Köse, S., Krarup, H., Lazarevic, I., Lunar, M.M., Maylin, S., Micheli, V., Mor, O., Paraschiv, S., Paraskevis, D., Poljak, M., Puchhammer-Stöckl, E., Simon, F., Stanojevic, M., Stene-Johansen, K., Tihic, N., Trimoulet, P., Verheyen, J., Vince, A., Weis, N., Yalcinkaya, T., Lepej, S.Z., Boucher, C.A., Wensing, A.M., Perno, C.F., and Svicher, V.
- Published
- 2016
- Full Text
- View/download PDF
18. Significance of UGT1A1*28 genotype in patients with advanced liver injury caused by chronic hepatitis C
- Author
-
Jordović Jelena, Bojović Ksenija, Simonović-Babić Jasmina, Gašić Vladimir, Kotur Nikola, Zukić Branka, Vuković Marija, Pavlović Sonja, Lazarević Ivana, Bekić Ivana, Nikolić Nataša, Urošević Aleksandar, Mitrović Nikola, and Delić Dragan
- Subjects
gilbert syndrome ,hepatitis c ,hyperbilirubinemia ,late relapse ,ugt1a1 ,Biochemistry ,QD415-436 - Abstract
Background: Chronic hepatitis C (CHC) is a significant cause of liver related morbidity and mortality worldwide. The role of genetics in the host response to hepatitis C virus is not elucidated. Genetic variations in UGT1A1 gene are the most common cause of hereditary unconjugated hyperbilirubinemia-Gilbert syndrome. This is the first study investigating the association of UGT1A1 TA repeats promoter genotypes with the degree of liver injury, viremia and biochemical markers in CHC patients with advanced liver injury and late virological relapse. Methods: Genetic testing of UGT1A1 TA repeats promoter genotypes was performed in 42 CHC patients with advanced fibrosis and cirrhosis who achieved sustained virological response and 42 healthy blood donors. CHC patients were evaluated for clinical findings, laboratory tests and imaging. Results: UGT1A1*28 genotype (7/7 TA repeats) was observed in 23.8% CHC patients and 16.7% healthy controls with no significant difference in genotype frequencies (p= 0.49). Pretreatment levels of ferritin and bilirubin were associated with the presence of U G T1A1*28 genotype, indicating its potential as a predictive marker. However, in our study, there was no correlation of U G T1A 1*28 genotype with the degree of fibrosis or viremia. During antiviral treatment, dose reductions and treatment interruptions, as well as treatment success and occurrence of late virological relapse were not related to the presence of U G T1A 1*28 genotype in CHC patients with severe liver injury. Conclusions: Frequencies of U G T1A 1*28 genotype are high in both Serbian CHC patients and healthy subjects. The presence of U G T1A 1*28 genotype was not associated with ribavirin-related adverse effects and had no effect on long term outcome in CHC patients.
- Published
- 2019
19. How to predict neurogenic pulmonary edema in aneurysmal subarachnoid hemorrhage?: Neurogenic pulmonary edema in aneurysmal SAH
- Author
-
Nastasović Tijana, Milaković Branko, Stošić Mila, Lazarević Ivana, Kaluđerović Miloš, and Grujičić Danica
- Subjects
subarachnoid haemorrhage ,neurogenic pulmonary edema ,cardiac biomarkers ecg changes ,Anesthesiology ,RD78.3-87.3 - Abstract
Introduction: Neurogenic pulmonary edema (NPE) is a clinical syndrome characterized by the acute onset of pulmonary edema after sudden raise of intracranial pressure. NPE is the result of release of catecholamines into the circulation immediately after intracranial hemorrhage. The aim of this study is to investigate a possible correlation between the values of cardiac biomarkers on admission and incidence of NPE in patients with aneurysmal subarachnoid hemorrhage (SAH). Methods: Prospective study includes 262 patients with SAH (162 females). Clinical characteristics, serum cardiac and inflammatory biomarkers were measured on admission and on the day of development of NPE. These data were analysed by tests of statistical significance and binary logistic regression analysis in order to predict the development of NPE. Results: 19 patients (7.25%) developed NPE. Statistical analysis revealed that patients who subsequently developed NPE experienced more severe SAH. Cardiac damage was more severe in these patients, as represented by significantly higher number of patients with elevated values of all examined cardiac biomarkers (P from < 0.001 to 0.004). Multivariate regression analysis revealed that elevated troponin I (OR 4.980; 95% CI 1.27-19.49, P = 0.021) and white blood cells count (OR 22.195; 95% CI 3.99-123.50, P < 0.001) were predictors of NPE. Conclusion: Significantly higher number of patients with elevated values of cardiac biomarkers had SAH complicated with NPE. Elevated values of cardiac biomarkers might play an active role in prediction of NPE, although white blood cells count may be involved in the prediction of NPE.
- Published
- 2019
20. The role of PCR in detection of cytomegalovirus in blood and urine of transplanted patients
- Author
-
Lazarevic, I., primary, Stanojevic, M., additional, Cupic, M., additional, and Jovanovic, T., additional
- Published
- 2006
- Full Text
- View/download PDF
21. Reshaping Clinical Trial Data Collection Process to Use the Advantages of the Web-Based Electronic Data Collection.
- Author
-
Jarm, Tomaz, Kramar, Peter, Zupanic, Anze, Pavlovic, Ivan, and Lazarevic, I.
- Abstract
In this paper some results of modeling web-based clinical trial electronic data collection process are presented. Clinical trial data collection is usually a paper-based process. Here we propose a new process of electronic data collection adjusted for the utilization of the web-based technology. Two models that we present here are the basis for the development of the electronic data collection software to support clinical trials. The first one defines use cases of the actors using the system. The second one is a model of the structure of the electronic Case Report Form (eCRF) document. Descriptions of these two models at a high level of abstraction are presented using the standard UML (Unified Modeling Language) version 2.0. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
22. Two Models Used as a Basis for Development of Electronic Data Collection Software to Support Clinical Trials.
- Author
-
Pavlovic, I. and Lazarevic, I.
- Published
- 2007
- Full Text
- View/download PDF
23. Intestinal parasitosis in asylum seekers from Middle East and South Asia
- Author
-
Relić Tijana, Kačarević Hranislav, Ilić Nevenka, Jovanović Dara, Tambur Zoran, Doder Radoje, and Lazarević Ivana
- Subjects
parasitic diseases ,refugees ,diagnosis ,feces ,serbia ,Medicine (General) ,R5-920 - Abstract
Background/Aim. It is estimated that about 230 million refugees and asylum seekers circulates worldwide. Parasitosis are diagnosed in recent years with increasing frequency both in Europe and other developed countries. International migration of population, as an inalienable part and a result of the process of globalization, has an increasing impact on health of the population of countries through which migrants pass or settle. The aim of this study was to determine the incidence of intestinal parasitic diseases in asylum seekers on the territory of Belgrade. Methods. The study group included 97 asylum seekers from the Centre for Asylum seekers in Obrenovac, in the period December 2013– January 2014. Stool samples were taken less than seven days after arriving to the Center and sent to the Laboratory for Parasitological Diagnosis of the Public Health Institute of Belgrade. Detection of parasites in stool samples was performed by a direct native slide made of fresh sample and direct slide made after stool concentration applying "Mini Parasep" technique. Statistical analysis included application of χ2-test of matching and χ2-test of independence. Results. The study showed that the parasites were detected in 9.3% of cases, in the group of 15–24 years of age. Protozoa were found in 6.2% and helminthes in 3.1% of the samples. Conclusion. Most intestinal parasitosis were found in asylum seekers from Bangladesh. All parasitosis were found in males and the most frequently detected parasite was Giardia lamblia.
- Published
- 2018
- Full Text
- View/download PDF
24. Respiratory syncytial virus infection and bronchial hyperreactivity in children up to two years of age in correlation with atopy
- Author
-
Relić Tijana, Ilić Nevenka, Kostić Gordana, Jovanović Dara, Tambur Zoran, and Lazarević Ivana
- Subjects
respiratory syncytial viruses ,bronchial diseases ,hypersensitivity ,immediate ,comorbidity ,child ,Serbia ,Medicine (General) ,R5-920 - Abstract
Background/Aim. Bronchiolitis in early childhood caused by respiratory syncytial virus (RSV) is considered to be important risk factor of the recurrent wheezing and asthma development. The aim of this study was to examine the frequency of RSV infection and atopy in children up to two years of age and to determine their correlation with bronchial hyperreactivity. Methods. The study included 175 children aged 5-24 months. The presence of RSV infection was identified by serum levels of IgA and IgG determined by ELISA. Bronchial hyperreactivity (BHR) has been defined as the existence of chronic bronchial disease and/or three or more previous suspected diagnosis of acute bronchial disease. Atopy was confirmed by detection of the specific serum IgE using quantitative multitest Phadiatop infant (cut off ≥ 0.35 kUA/L). Results. The children with atopy were more frequently infected with RSV (43.3%) than those without atopy (22.8%; p = 0.02). The higher frequency of RSV infection was found in children with BHR in comparison with those without it but only in the group who also had atopy (77.8% vs 28.6%, p = 0.018). In the female children, BHR and RSV infection were associated in 62.5% of cases, regardless the atopy. In the male children with atopy, RSV infection was associated with BHR in 83.3% of the cases, while in those without atopy, RSV infection with BHR was found in only 17.4% of the cases. Conclusion. Children up to two years of age with atopy are more frequently infected with RSV (43.3%) than non-atopic children. Every third child with atopy develops BHR and 77.8% of them also have RSV infection. Atopic children are at higher risk for development of BHR when infected with RSV also.
- Published
- 2016
- Full Text
- View/download PDF
25. Analysis of the variability of Epstein-Barr virus genes in infectious mononucleosis: Investigation of the potential correlation with biochemical parameters of hepatic involvement
- Author
-
Banko Ana, Lazarević Ivana, Stevanović Goran, Ćirković Anđa, Karalić Danijela, Ćupić Maja, Banko Bojan, Milovanović Jovica, and Jovanović Tanja
- Subjects
ebv ,gene polymorphism ,infectious mononucleosis ,lm p1 ,transaminase ,Biochemistry ,QD415-436 - Abstract
Background: Primary Epstein-Barr virus (EBV) infection is usually asymptomatic, although at times it results in the benign lymphoproliferative disease, infectious mononucleosis (IM), during which almost half of patients develop hepatitis. The aims of the present study are to evaluate polymorphisms of EBV genes circulating in IM isolates from this geographic region and to investigate the correlation of viral sequence patterns with the available IM biochemical parameters. Methods: The study included plasma samples from 128 IM patients. The genes EBNA2, LM P1, and EBNA1 were amplified using nested-PCR. EBNA2 genotyping was performed by visualization of PCR products using gel electrophoresis. Investigation of LM P1 and EBNA1 included sequence, phylogenetic, and statistical analyses. Results: The presence of EBV DNA in plasma samples showed correlation with patients' necessity for hospitalization (p= 0.034). The majority of EBV isolates was genotype 1. LMP1 variability showed 4 known variants, and two new deletions (27-bp and 147-bp). Of the 3 analyzed attributes of LM P1 isolates, the number of 33-bp repeats less than the reference 4.5 was the only one that absolutely correlated with the elevated levels of transaminases. EBNA1 variability was presented by prototype subtypes. A particular combination of EBNA2, LM P1, and EBNA1 polymorphisms, deleted LM PI/P-thr and non-deleted LMp1/P-ala, as well as genotype 1/ 4 .5 33-bp LM P1 repeats or genotype 2 / 4 .5 33-bp LM P1 repeats showed correlation with elevated AST (aspartate aminotransferase) and ALT (alanine transaminase). Conclusions: This is the first study which identified the association between EBV variability and biochemical parameters in IM patients. These results showed a possibility for the identification of hepatic related diagnostic EBV markers.
- Published
- 2016
26. Design and analysis of the flat honeycomb sandwich structures
- Author
-
Petrović Zoran and Lazarević Ivan
- Subjects
sandwich structure ,honeycomb core ,application in aviation ,aircraft ,aircraft structure ,face ,structural analysis ,finite element analysis ,Technology ,Engineering (General). Civil engineering (General) ,TA1-2040 - Abstract
Structural sandwich is a unique form of the composite structure, and it finds a widespread use in the aerospace industry, where weight saving is a primary concern. The major difference between analysis procedures for sandwich construction and those for homogeneous structural elements is the inclusion of core shear effects on deflection, buckling and stress. The design procedure given in this article is intended to guide the designer in sizing the sandwich parts for primary loading properly. These procedures are usually iterative, and optimum design may require the design of several face-core combinations. Comparing the results obtained through the analytical procedure and Finite Element Analysis (FEA) one can conclude their good agreement. Differences for most of the results are from 10% to 15%, which is quite satisfactory, taking into account that the analytical models are formed on the basis of a number of assumptions and approximations.
- Published
- 2015
27. Failure investigation: Analysis procedure and some notable aircraft and aeroengine service failures
- Author
-
Lazarević Ivan and Petrović Zoran
- Subjects
aircraft ,helicopter ,propeller ,rotor of the helicopter ,corrosion ,failure ,analysis of processes ,fractography ,Technology ,Engineering (General). Civil engineering (General) ,TA1-2040 - Abstract
Failure of an aircraft structural component can have catastrophic consequences, with a resultant loss of life and of the aircraft. The investigation of defects and failures in aircraft structures is, thus, of the vital importance in preventing further incidents. This review discusses the common failure modes observed in aircraft structures, with examples drawn from case histories. A review has given three notable aircraft and aeroengine service failures investigated by the National Aerospace Laboratory NLR in the Netherlands. All three failures were initiated by a corrosion.
- Published
- 2015
28. Genetic variability of the VP1 gene of BK and JC polyomaviruses in HIV-infected patients
- Author
-
Karalić Danijela and Lazarević Ivana
- Subjects
BKV ,JCV ,HIV ,mutations ,VP1 ,Medicine - Abstract
Human polyomaviruses, BK virus (BKV) and JC virus (JCV), are world widely distributed in human population. After primary infection, BKV and JCV establish latency in kidneys and upper part of urinary tract. In seropositive healthy individuals asymptomatic reactivation of both viruses occurs in in 0.5-20%. On the other hand, reactivation of these viruses in imunosuppressed patients, primarily in patients with T cell immunodeficiency, can lead to development of polyomavirus-associated diseases. Some of these diseases such as progressive multifocal leukoencephalopathy (PML), polyomavirus-induced nephropathy (PVN), hemorrhagic cystitis (HC) are life-threatening diseases with high mortality and morbidity rate. However, they do not affect all immunosuppressed patients, suggesting that other factors, such as genetic variability of BKV and JCV, can contribute to their occurrence. Immunosuppression leads to increased levels of replication of both viruses. Increased levels of replication are associated with higher incidence of mutations in the VP1 gene. Mutations, especially those located in outer loops, may lead to changed tropism and generation of more aggressive variants of BKV and JCV. This review is focused on clinical significance of BK and JC virus infection in immunosuppressed patients, especially in HIV-infected, and sequence changes in the VP1 gene that can contribute to selection of more virulent variants of BKV and JCV via adaptive evolution.
- Published
- 2015
- Full Text
- View/download PDF
29. The use of forests in the river Zagrža basin for the conservation of its hydrological and water protective function
- Author
-
Letić Ljubomir, Nikolić Vesna, Lazarević Ivica, and Savić Radovan
- Subjects
protective forests ,beech ,fir ,hydrological forest function ,water quality ,the use of woody and non-woody sources ,Forestry ,SD1-669.5 - Abstract
The data on forests shown in this paper which are general useful functions determine the main way of managing, because these forests are marked as water protective and especially significant for the water supply of the Vrnjačka Banja area from 1985. These are forests of beech and beech mixed with fir of the highest quality located in the river Zagrža basin on mountain Goč and they represent more than 85 % of the basin and provide the hydrological and water protective functions at the highest level. For that reason, they have a special protective status. In the river Zagrža basin, there is the management unit "Selište" of particular importance and the accumulation Selište was built there with about 380 000 m3 volume and its primary task is water supply of the Vrnjačka Banja area during critical months without water. The aim of this scientific paper is to emphasize the need of increasing and protecting the water potential using adequate ways of forest vegetation management, which means overall basin organization. The final result should be related to the optimal use of natural sources in that area.
- Published
- 2015
- Full Text
- View/download PDF
30. Characteristics of Norovirus infection in Serbia
- Author
-
Relić Tijana, Begović-Lazarević Ivana, Pavlović Nevenka, Ilić Nevenka, Kačarević Hranislav, Jovanović Dara, Kostić Gordana, and Lazarević Ivana
- Subjects
norovirus ,gastroenteritis ,incidence ,risk assessment ,disease outbreaks ,Serbia ,Medicine (General) ,R5-920 - Abstract
Background/Aim. Norovirus (NoV), formerly Norwalk-like virus is the most common cause of acute gastroenteritis in humans of all ages. It is known that 90% of viral gastroenteritis and about 60-85% of all outbreaks of gastroenteritis, especially in the territory of United States of America, Europe and Japan are caused by this virus. For the countries of the northern hemisphere, individual cases and outbreaks of acute NoV gastroenteritis appear in seasonal pattern, mainly during the winter months. The aim of this study was to describe characteristics of acute gastroenteritis with the established NoV etiology in Serbia. Methods. The study group included 88 patients with the symptoms of acute gastroenteritis, throughout the year 2010 and 2011. From all the patients, stool samples were taken less than three days from the onset of symptoms. Detection of NoV in stool samples was performed by commercial qualitative immuno-chromatography assay. Statistical analysis included application of χ2 test, Mann-Whitney U-test, Kruskal-Wallis's test, Spearman’s rank correlation test and logistic regression analysis. Results. Outbreaks of acute gastroenteritis caused by NoV were recorded to be the most common in children with the incidence of infection of 50% in the age group 0-15 years. Analysis of individual symptoms in the NoV proven infection, showed that diarrhea was the most common symptom, followed by vomiting especially in small children, while abdominal pain was most common in elderly (≥ 65 years). The presence of frequent vomiting, more than 4 times/day, indicated NoV infection in the women, while for men the infection was always presented with diarrhea. Conclusion. The obtained results confirmed that small children and elderly are the most susceptible to NoV infection and that out-breaks are more frequent in the winter months. Those who consumed food in restaurants and other public facilities were not at higher risk for NoV infection.
- Published
- 2015
- Full Text
- View/download PDF
31. Distribution of macrolide-resistant genes among isolates of macrolideresistant Streptococcus pyogenes and Streptococcus pneumoniae in Serbia
- Author
-
Gajić Ina, Mijač Vera, Opavski Nataša, Stanojević Maja, Lazarević Ivana, Šmitran Aleksandra, Hadnađev Mirjana, and Ranin L.
- Subjects
Streptococcus pyogenes ,Streptococcus pneumoniae ,macrolide resistance ,Biology (General) ,QH301-705.5 - Abstract
Macrolide resistance in Streptococcus pneumoniae and in group A streptococci (GAS) is a significant problem worldwide. In Serbia, data on the mechanisms of resistance and the corresponding resistance genes in streptococci are largely lacking. Therefore, we analyzed the distribution of macrolide resistance phenotypes and genotypes in 44 macrolideresistant GAS (MRGAS) and 50 macrolide-resistant S. pneumoniae (MRSP) isolates collected in the same period. The double disk diffusion test and PCR were used to analyze resistance phenotypes and resistance genes, respectively. Among MRSP, the MLSB phenotype dominated, whereas the M phenotype was the most prevalent among MRGAS isolates. Consequently, in MRSP, the ermB gene was the most common (n=40, 80%), followed by the mefA gene (n=7,14%). In MRGAS strains, mefA dominated (n=27,61%), followed by ermA (n=15, 33%) and ermB (n=3, 7%). In 3 MRSP isolates no resistance genes were detected, while one MRGAS strain with iMLSB phenotype harbored both ermA and mefA genes.
- Published
- 2014
- Full Text
- View/download PDF
32. Prevalence of JC and BK polyomavirus excretion in the urine of HIV-infected patients from Serbia
- Author
-
Karalić Danijela, Lazarević Ivana, Ćupić Maja, Jevtović Đ., and Jovanović Tanja
- Subjects
JC virus ,BK virus ,HIV-infection ,immunosuppression ,urinary excretion ,Biology (General) ,QH301-705.5 - Abstract
BK virus (BKV) and JC virus (JCV) persist as latent infection in the kidneys. Reactivation of both viruses may be linked to immunodeficiency. The aims of this study were to determine the prevalence of BKV and JCV viruria and to evaluate the relationship between immunodeficiency and viruria in a cohort of HIV-infected patients. Urine samples from 93 HIV-infected patients were collected and tested for the presence of BKV and JCV DNA by PCR. The overall prevalence of polyomavirus DNA in urine was 74.2%. BKV DNA was detected in 30.1% urine samples and JCV DNA in 23.7% samples. Both BKV and JCV DNA were detected in 20.4% samples. There was no association between BKV/JCV urinary shedding and the degree of immunosuppression measured by CD4+ cell count. However, taking into account the severity of disease resulting from reactivation of BKV and JCV, patients with HIV/polyomavirus co-infection should be kept under frequent and regular supervision. [Projekat Ministarstva nauke Republike Srbije, br. 175073]
- Published
- 2014
- Full Text
- View/download PDF
33. The role of single nucleotide polymorphisms of cytokine genes in viral infections
- Author
-
Ćupić Maja, Pravica Vera, Lazarević Ivana, Banko Ana, Karalić Danijela, Tasić Dijana, and Jovanović Tanja
- Subjects
SNP ,IL-12B ,TNF-α ,IL-28B ,CMV ,kidney recipients ,HPV ,cervical cancer ,hepatitis C ,SVR ,Biology (General) ,QH301-705.5 - Abstract
Gene polymorphisms result from evolutionary processes representing mutations that survive in the population with a frequency higher than 1%. The most investigated type of gene polymorphisms are single nucleotide polymorphisms (SNPs). The SNPs of IL-12B (rs 3212227) A/C among a population of kidney graft CMV-seropositive recipients have an impact on a clinical events in cytomegalovirus (CMV) disease. Constitutive -308 G/A TNF-α polymorphism (rs1800629) is related to the susceptibility of HR-HPV-associated cervical dysplasia and cancer. SNP located 3 kb upstream of the IL- 28B gene (rs12979860) seems to be the strongest host genetic predictor of sustained virologic response (SVR) in hepatitis C genotype 1 patients. It is very important to identify viral and host genetic markers that may facilitate the risk of developing viral disease or some viral-associated cancers. In addition, these markers could be useful in the choice of effective treatments and preventive strategies against virally induced infection. [Projekat Ministarstva nauke Republike Srbije, br. 175073 i br. 175038]
- Published
- 2014
- Full Text
- View/download PDF
34. Prevalence and mutational patterns of lamivudine-resistant HBV strains in chronically infected Serbian patients
- Author
-
Lazarević Ivana, Ćupić Maja, Banko Ana, Karalić Danijela, Delić D., Švirtlih Neda, Simonović Jasmina, and Jovanović Tanja
- Subjects
Hepatitis B virus (HBV) ,lamivudine ,resistance ,mutations ,Biology (General) ,QH301-705.5 - Abstract
This study aimed to determine the prevalence and mutational patterns of lamivudine-resistant hepatitis B virus (HBV) strains in chronically infected Serbian patients. The study included 154 patients on long-term lamivudine monotherapy. Resistance-associated mutations were identified by direct sequencing of the S/P gene. The genotypic resistance to lamivudine was confirmed in 54.5% of patients. Three primary resistance-associated mutations were found: rtM204V (55.9%), rtM204I (40.5%), rtA181T (3.6%) and two compensatory mutations rtV173L (17.8%) and rtL180M (67.8%). Seven mutational patterns were discovered with rtL180M+rtM204V being dominant (41.6%). The presence of resistance associated mutations was correlated to the older age of patients, the presence of clinically relevant HBsAg mutations and higher values of viral load. No correlation with HBV genotypes, subgenotypes or HBsAg subtypes was observed. High prevalence of resistance supports the use of genotypic testing in monitoring patients on lamivudine therapy and selecting those who would benefit from therapy with newly developed nucleos(t)ide analogs. [Projekat Ministarstva nauke Republike Srbije, br. 175073]
- Published
- 2014
- Full Text
- View/download PDF
35. Prevalence of Epstein Barr Virus in biopsy specimens of nasopharyngeal carcinoma from Serbian patients
- Author
-
Banko Ana, Lazarević Ivana, Folić M., Ćupić Maja, and Jovanović Tanja
- Subjects
Epstein-Barr Virus (EBV) ,nasopharyngeal carcinoma (NPC) ,smoking ,TNM staging ,Biology (General) ,QH301-705.5 - Abstract
The development of nasopharyngeal carcinoma (NPC) is the result of interaction between Epstein-Barr Virus (EBV) and many non-viral factors. The aims of this study were to determine the prevalence of EBV in NPC biopsies from Serbian patients and to investigate the correlation between EBV presence and demographic, anamnestic and clinical data. Ninety-three tissue blocks were included. For detection of EBV DNA, the C terminus of the LMP1 gene was amplified by nested-PCR. Twenty-eight biopsies were EBV-DNA-positive (30.1%), with a statistically significant difference in EBV DNA presence between geographical regions (p=0.02) and between the stages of tumor-node-metastasis (TNM) (p=0.02). A correlation was also found with the presence of EBV DNA and smoking (p=0.02). The correlation of EBV DNA presence, with or without smoking and the promising outcome of the disease was statistically significant (p=0.02; p=0.01). The EBV DNA findings from this study confirm the role of EBV in NPC carcinogenesis, and show the different distribution among TNM stages and correlation between the virus and outcome of disease. [Projekat Ministarstva nauke Republike Srbije, br. 175073]
- Published
- 2014
- Full Text
- View/download PDF
36. Possibilities of implementing progesterone EIA test in the control of reproduction in dairy cows
- Author
-
Barna S. Tomislav,, Milovanović M. Aleksandar, Lazarević I. Miodrag, and Gvozdić M. Dragan
- Subjects
β-carotene ,cows ,EIA test ,hCG ,milk ,progesterone ,Veterinary medicine ,SF600-1100 - Abstract
The aim of this study was to implement the progesterone EIA test, developed in our laboratory by using an anti-progesterone antibody (Yamaguchi University, Japan), in order to determine the optimal moment for artificial insemination (AI) and to detect pregnancy in Holstein-Friesian cows according to the progesterone concentration in the whole milk. Also, the influence of β-carotene, applied at the day of insemination and human chorionic gonadotrophin applied on day 7 after AI on the progesterone level and the pregnancy rate were evaluated.For the accuracy of oestrus detection, the milk samples from 70 cows were collected on the day of insemination. Milk samples from 148 cows were collected 19-22 days following insemination for pregnancy check.After detection of naturally occurring oestrus (day 0) and AI, cows were divided into the following groups: group A (n = 19) was treated with 200 mg β-carotene (20 ml Carofertin® i.m. Alvetra u. Werfft Gmbh, Austria), group B (n = 17) was treated with 1 500 IU hCG i.m. (Schering-Plough, the Netherlands) and control (non treated) group C (n = 18). The milk samples for EIA progesterone concentration analysis were collected on the day of AI, the 14th and the 20th day of the oestrus cycle. Oestrus detection errors and inappropriate moments of insemination according to the progesterone concentration were detected in 22.86% animals (16/70). The test accuracy for non-pregnant cows was 90.48% (76/84). The accuracy of the progesterone test in pregnant cows was 75% (48/64). False positive results (high progesterone level, but the cows were not pregnant) was detected in 25% of cows (16/64) as a result of a prolonged oestrus cycles, embrional mortality and endomethritis (10/16 cases). The treatment of cows with 1500 IU of hCG, on the day 7 of the oestrus cycle, resulted in statistically significant increase of progesterone concentration in the dioestrus (P < 0.01). The most successful insemination was in the group of cows that was treated with hCG (47.05%; 8/17), then in the control group (38.88%; 7/18) and the least in the Carofertin group - 36.84% (7/19). These differences were only numerical (p>0.05).The EIA test developed in our laboratory could be used for accurate progesterone determination in the whole milk during implementation of different methods for control of bovine reproduction.
- Published
- 2013
37. Complete genome sequences and phylogenetic analysis of Hepatitis B virus isolates from Serbia
- Author
-
Lazarević Ivana, Ćupić Maja, Delić D., Stojković-Svirtlih Neda, Simonović Jamina, Banko Ana, and Jovanović Tanja
- Subjects
Hepatitis B virus (HBV) ,genome ,genotype ,phylogenetic analysis ,Biology (General) ,QH301-705.5 - Abstract
Although the genotype and subgenotype distribution of HBV isolates from Serbia has previously been reported, data about whole genome sequences from this area are scarce. This study included plasma samples from 5 chronically infected patients. Full genome amplification of the HBV isolates was performed by nested-PCR using 7 primer pairs, and the whole genome nucleotide sequences were obtained by direct sequencing. Two complete genome sequences belonged to D2 subgenotype (ayw3 HBsAg subtype), one to D1 (ayw2) and two to A2 (adw2). All 5 Serbian isolates clustered with sequences from the expected geographic regions and had nucleotide and coded protein length in accordance to their assigned genotypes, except for one HBeAg-negative isolate displaying G1896A mutation leading to a premature stop codon in the Pre-C region. The first complete genome sequences of HBV D1, D2 and A2 subgenotypes from Serbian patients showed characteristics similar to the nucleotide sequences of HBV isolates from other European and Middle East countries. [Projekat Ministarstva nauke Republike Srbije, br. 175073]
- Published
- 2012
- Full Text
- View/download PDF
38. The prevalence of human polyomaviruses in urine samples of immunocompetent individuals in the Serbian population
- Author
-
Karalić Danijela, Lazarević Ivana, Ćupić Maja, and Jovanović Tanja
- Subjects
human polyomaviruses ,immunocompetent ,urinary excretion ,Biology (General) ,QH301-705.5 - Abstract
The BK (BKV) and JC viruses (JCV) are human polyomaviruses. After primary infection, they persist as latent infection in the kidneys. Immunosuppression leads to their reactivation, which is associated with life-threatening diseases such as polyomavirus-induced nephropathy and progressive multifocal leukoencephalopathy. However, the behavior of these viruses in immunocompetent individuals is still an open question with no right answer. The aim of this study was to determine the prevalence of BKV and JCV shedding in the urine of immunocompetent individuals from the Serbian population. Sixty-five urine samples were collected and tested for the presence of BKV and JCV DNA by PCR. JCV DNA was detected in 19/65 (29.2%) and BKV DNA in 3/65 (4.6%) of the urine samples. Forty-three (66.2%) urine samples of the immunocompetent donors were negative for both viruses. The present study provides the first results of urinary excretion of human polyomaviruses in the Serbian population. [Projekat Ministarstva nauke Republike Srbije, br. 175073]
- Published
- 2012
- Full Text
- View/download PDF
39. The prevalence of the most important viral infections in renal transplant recipients in Serbia
- Author
-
Ćupić Maja, Lazarević Ivana, Pravica Vera, Banko Ana, Karalić Danijela, Naumović R., Kravljača Milica, and Jovanović Tanja
- Subjects
Kidney transplantation ,viral infections ,renal transplant recipients ,viral and molecular diagnostic procedures ,Biology (General) ,QH301-705.5 - Abstract
Viruses are the main cause of opportunistic infections after kidney transplantation. The aim of this study was to determine the prevalence of cytomegalovirus (CMV), Epstein-Barr virus (EBV), B. K. virus (BKV) and John Cunningham virus (JCV) infections in renal transplant recipients (RTR). This retrospective study of 112 RTR investigated the presence of CMV, EBV and polyomaviruses DNA in plasma and/or urine by PCR. The visualization of PCR products was performed by electrophoresis on 2% agarose gel stained with ethidium bromide and photographed under a UV light. The chi-square test was used for statistical analysis. CMV DNA was detected in 14/112 (12.5%), EBV DNA in 4/49 (8.16%), BKV DNA in 10/31 (32.26%) and JCV DNA in 3/31 (9.68%) RTR. These results show that CMV infection is more often present in RTR compared to other investigated viral infections. In the light of these results, molecular testing could be useful in identifying recipients at high risk of symptomatic post-transplant viral infection. [Projekat Ministarstva nauke Republike Srbije, br. 175073, br. 175038 and br. 175089]
- Published
- 2012
- Full Text
- View/download PDF
40. Approximation properties of a sequence of linear positive operators.
- Author
-
Lupas, A., Lazarevic, I., Lupas, A., and Lazarevic, I.
41. Oncogenic viruses and their role in tumor formation
- Author
-
Ćupić Maja, Lazarević Ivana, and Kuljić-Kapulica Nada
- Subjects
human oncoviruses ,molecular oncogenic mechanisms ,DNA oncogenic viruses ,RNA oncogenic viruses ,Medicine - Abstract
Oncogenic viruses trigger persistent infections, which can stimulate uncontrolled cell growth by inducing cell transformation. Different oncogenic viruses use different mechanisms for infecting cells. Most oncogenic DNA viruses integrate transforming sets of genes into the host chromosome and encode proteins that bind and inactivate cell growth regulatory proteins, such as p53 and retinoblastoma gene product. Tumorous RNA viruses use different oncogenic mechanisms. Some of them encode oncogenic proteins that are almost identical to the cellular proteins involved in the control of cellular growth. The overproduction or altered function of these oncogenic materials stimulates cell growth. These RNA viruses can cause tumors rapidly. The second group of oncoviruses integrates their promoter sequences and viral enhancers near to the cellular growth-stimulating gene, initiating the transformation of the cell. The third group of RNA tumor viruses encodes a protein tax that transactivates the expression of cellular genes. Virus-induced malignant transformation of the cell represents the first step in the complex process of oncogenesis.
- Published
- 2005
- Full Text
- View/download PDF
42. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe
- Author
-
Tülay Yalcinkaya, Pascale Trimoulet, Valeria Micheli, Adriana Vince, G. J. Boland, Maja M. Lunar, Jens Verheyen, Carlo Federico Perno, Bianca Bruzzone, Charles A. Boucher, Henrik Krarup, Sarah Maylin, Sukran Kose, Nicola Coppola, Kathrine Stene-Johansen, Annemarie M. J. Wensing, Rolf Kaiser, François Simon, Maja Stanojevic, Lucas Etienne Hermans, Mario Poljak, Simona Paraschiv, Nijaz Tihic, Valentina Svicher, L. Colagrossi, Ziv Ben-Ari, Tomasz Dyda, Federico García, Orna Mor, Ivana Lazarevic, Marta Álvarez, Nina Weis, Suzan D. Pas, Snjezana Zidovec Lepej, Carole Seguin-Devaux, Elisabeth Puchhammer-Stöckl, Domenico Di Carlo, Romina Salpini, Dimitros Paraskevis, Virology, Colagrossi, L, Hermans, Le, Salpini, R, Di Carlo, D, Pas, Sd, Alvarez, M, Ben-Ari, Z, Boland, G, Bruzzone, B, Coppola, N, Seguin-Devaux, C, Dyda, T, Garcia, F, Kaiser, R, Köse, S, Krarup, H, Lazarevic, I, Lunar, Mm, Maylin, S, Micheli, V, Mor, O, Paraschiv, S, Paraskevis, D, Poljak, M, Puchhammer-Stöckl, E, Simon, F, Stanojevic, M, Stene-Johansen, K, Tihic, N, Trimoulet, P, Verheyen, J, Vince, A, Lepej, Sz, Weis, N, Yalcinkaya, T, Boucher, Cab, Wensing, Amj, Perno, Cf, and Svicher, V
- Subjects
Adult ,Male ,0301 basic medicine ,Immune-escape ,Hepatitis B virus ,medicine.medical_specialty ,HBsAg ,Genotype ,Medizin ,Drug resistance ,medicine.disease_cause ,Antiviral Agents ,Virus ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,Hepatitis B, Chronic ,0302 clinical medicine ,Medical microbiology ,medicine ,HBV ,Humans ,Stop-codons ,lcsh:RC109-216 ,Drug-resistance ,Mutation ,Hepatitis B Surface Antigens ,business.industry ,Middle Aged ,Settore MED/07 - Microbiologia e Microbiologia Clinica ,Virology ,Stop codon ,3. Good health ,Europe ,030104 developmental biology ,Infectious Diseases ,Amino Acid Substitution ,Parasitology ,Codon, Terminator ,Female ,030211 gastroenterology & hepatology ,business ,Research Article - Abstract
Background HBsAg immune-escape mutations can favor HBV-transmission also in vaccinated individuals, promote immunosuppression-driven HBV-reactivation, and increase fitness of drug-resistant strains. Stop-codons can enhance HBV oncogenic-properties. Furthermore, as a consequence of the overlapping structure of HBV genome, some immune-escape mutations or stop-codons in HBsAg can derive from drug-resistance mutations in RT. This study is aimed at gaining insight in prevalence and characteristics of immune-associated escape mutations, and stop-codons in HBsAg in chronically HBV-infected patients experiencing nucleos(t)ide analogues (NA) in Europe. Methods This study analyzed 828 chronically HBV-infected European patients exposed to ≥ 1 NA, with detectable HBV-DNA and with an available HBsAg-sequence. The immune-associated escape mutations and the NA-induced immune-escape mutations sI195M, sI196S, and sE164D (resulting from drug-resistance mutation rtM204 V, rtM204I, and rtV173L) were retrieved from literature and examined. Mutations were defined as an aminoacid substitution with respect to a genotype A or D reference sequence. Results At least one immune-associated escape mutation was detected in 22.1% of patients with rising temporal-trend. By multivariable-analysis, genotype-D correlated with higher selection of ≥ 1 immune-associated escape mutation (OR[95%CI]:2.20[1.32–3.67], P = 0.002). In genotype-D, the presence of ≥ 1 immune-associated escape mutations was significantly higher in drug-exposed patients with drug-resistant strains than with wild-type virus (29.5% vs 20.3% P = 0.012). Result confirmed by analysing drug-naïve patients (29.5% vs 21.2%, P = 0.032). Strong correlation was observed between sP120T and rtM204I/V (P
- Published
- 2018
- Full Text
- View/download PDF
43. Quantitative HBV Core Antibodies as a Prognostic Marker for HBeAg Seroclearance: A Systematic Review with Meta-Analysis.
- Author
-
Lazarevic I, Miljanovic D, Banko A, Cupic M, and Cirkovic A
- Subjects
- Humans, Prognosis, Hepatitis B Core Antigens immunology, Hepatitis B Core Antigens blood, Hepatitis B e Antigens blood, Hepatitis B e Antigens immunology, Hepatitis B Antibodies blood, Hepatitis B Antibodies immunology, Biomarkers blood, Hepatitis B, Chronic immunology, Hepatitis B, Chronic diagnosis, Hepatitis B, Chronic virology, Hepatitis B, Chronic blood, Hepatitis B virus immunology
- Abstract
During chronic hepatitis B virus (HBV) infection, the seroclearance of hepatitis B e antigen (HBeAg) is an important event and a significant surrogate endpoint of all current therapeutic strategies. The prediction of HBeAg seroclearance can help assess the benefits of therapy in patients during or before therapy initiation. The quantitation of HBV core antibodies (qAnti-HBc) is a new non-invasive biomarker for solving multiple diagnostic dilemmas. A systematic review and meta-analysis of studies that measured qAnti-HBc in patients who achieved HBeAg seroclearance were performed through PubMed, Web of Science (WoS) and SCOPUS electronic database searches. Nineteen articles were included in the systematic review, comprising 3434 chronically infected patients (1014 with and 2420 without HBeAg seroclearance). Sixteen publications with data regarding qAnti-HBc levels were included in the meta-analysis. The baseline level of qAnti-HBc antibodies was significantly higher in patients with than without HBeAg seroclearance (SMD = 0.88, 95%CI SMD = 0.56-1.2, p < 0.001). The same conclusion was reached for patients originating from Asia (SMD = 0.94, 95%CI SMD = 0.55-1.33) and for the qAnti-HBc antibodies among adult HBV patients with therapy-induced HBeAg seroclearance (SMD = 0.90, 95%CI SMD = 0.54-1.25, p < 0.001). The systematic review and meta-analysis provide evidence of the role of qAnti-HBc as a promising biomarker for predicting HBeAg seroclearance in chronically infected patients.
- Published
- 2024
- Full Text
- View/download PDF
44. Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies.
- Author
-
Lazarevic I, Banko A, Miljanovic D, and Cupic M
- Abstract
The hepatitis B surface antigen (HBsAg) is a multifunctional glycoprotein composed of large (LHB), middle (MHB), and small (SHB) subunits. HBsAg isoforms have numerous biological functions during HBV infection-from initial and specific viral attachment to the hepatocytes to initiating chronic infection with their immunomodulatory properties. The genetic variability of HBsAg isoforms may play a role in several HBV-related liver phases and clinical manifestations, from occult hepatitis and viral reactivation upon immunosuppression to fulminant hepatitis and hepatocellular carcinoma (HCC). Their immunogenic properties make them a major target for developing HBV vaccines, and in recent years they have been recognised as valuable targets for new therapeutic approaches. Initial research has already shown promising results in utilising HBsAg isoforms instead of quantitative HBsAg for correctly evaluating chronic infection phases and predicting functional cures. The ratio between surface components was shown to indicate specific outcomes of HBV and HDV infections. Thus, besides traditional HBsAg detection and quantitation, HBsAg isoform quantitation can become a useful non-invasive biomarker for assessing chronically infected patients. This review summarises the current knowledge of HBsAg isoforms, their potential usefulness and aspects deserving further research.
- Published
- 2024
- Full Text
- View/download PDF
45. Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus.
- Author
-
Banko A, Cirkovic A, Miskovic R, Jeremic I, Grk M, Basaric M, Lazarevic I, Raskovic S, Despotovic A, and Miljanovic D
- Subjects
- Humans, Herpesvirus 4, Human, Antigens, Viral, Immunoglobulin G, Epstein-Barr Virus Infections complications, Epstein-Barr Virus Infections epidemiology, Lupus Erythematosus, Systemic complications, Lupus Erythematosus, Systemic diagnosis
- Abstract
Introduction: The relationship between Systemic lupus erythematosus (SLE) and Epstein-Barr virus (EBV) infection has been suggested for decades, but the underlying mechanism of the EBV influence on SLE development remains to be elucidated., Methods: The goals of this research, which included 103 SLE patients and 99 controls, were to investigate the association of the parameters of EBV infection and SLE, to explore whether pooled demographic, clinical and EBV markers achieve a more significant effect on SLE development than each of them individually, and to evaluate EBV nuclear antigen 1 (EBNA1) and latent membrane protein 1 (LMP1) gene polymorphisms in isolates from SLE patients., Results: Comprehensive results related to serological, molecular and sequence markers of EBV infection in SLE patients demonstrated even 24 times higher possibility of having SLE if there is the presence of anti-EBV-EA(D) (early antigen) IgG antibodies (OR=24.086 95%CI OR=2.86-216.07, p=0.004). There was the same distribution of glucocorticoids (p=0.130), antimalarials (p=0.213), and immunosuppressives (p=0.712) in anti-EBV-EA(D) IgG positive and negative SLE patients. Further, higher anti-EBV-EA(D) IgG antibodies titers were identified as independent factors associated with lymphopenia, hematological SLE manifestation (OR=1.041, 95%CI OR=1.01-1.08, p=0.025, while a higher titer of anti-CA (viral capsid antigen) IgG antibodies (OR=1.015, 95%CI OR=1.01-1.03, p=0.019) and positive RF (rheumatoid factors) (OR=4.871, 95%CI OR=1.52-15.61, p=0.008) were identified as independent factors associated with alopecia within SLE. Finally, novel data on EBV EBNA1 and LMP1 gene polymorphisms in lupus are reported., Conclusion: The results support further investigation targeting EBV as a prognostic marker and therapeutic goal for lupus., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Banko, Cirkovic, Miskovic, Jeremic, Grk, Basaric, Lazarevic, Raskovic, Despotovic and Miljanovic.)
- Published
- 2023
- Full Text
- View/download PDF
46. Uncovering the Role of Epstein-Barr Virus Infection Markers for Remission in Rheumatoid Arthritis.
- Author
-
Banko A, Cirkovic A, Jeremic I, Basaric M, Grk M, Miskovic R, Lazarevic I, and Miljanovic D
- Abstract
Epstein-Barr virus (EBV) infection has been shown as a potential risk factor for the development of rheumatoid arthritis (RA). This prospective research aimed to investigate whether EBV infection markers changed during the six-month follow-up period in 133 RA patients (80 newly diagnosed on methotrexate (MTX)-RA-A, and 53 on biologic therapy-RA-B) and whether it was related to a disease outcome. Reduction of disease activity and inflammation was obtained. A significant decline in seroprevalence and titer for anti-VCA-IgM ( p = 0.022 and p = 0.026) and anti-EA(D)-IgM ( p = 0.022 and p = 0.006) in RA-A, and in seroprevalence and titer of anti-EA(D)-IgG in the RA-B subgroup ( p = 0.021 and p = 0.006) were detected after the follow-up. A lower titer of anti-EBNA1-IgG could be considered a significant marker of RA remission in all RA patients regardless of age and gender (OR = 0.99, 95% CI OR = 0.98-0.99, p = 0.038), and also in RA-B patients separately (OR = 0.988, 95% CI OR = 0.98-0.99, p = 0.041). This study supported the basic hypothesis that the immune response to EBV infection is involved in the RA pathogenesis, at the beginning of the disease or during the RA evolution. Moreover, the potential influence of MTX or TNF-alpha inhibitors on the impairment of the host to control EBV infection was indirectly refuted.
- Published
- 2023
- Full Text
- View/download PDF
47. Markers of Epstein-Barr Virus Infection in Association with the Onset and Poor Control of Rheumatoid Arthritis: A Prospective Cohort Study.
- Author
-
Miljanovic D, Cirkovic A, Jermic I, Basaric M, Lazarevic I, Grk M, Miskovic R, Despotovic A, and Banko A
- Abstract
Although the connection between Epstein-Barr virus (EBV) and rheumatoid arthritis (RA) has been studied for over 40 years, many questions still need clarification. The study aimed to analyze the possible association between anti-EBV antibody titers, EBV DNA viremia, EBV infection status and EBNA1 (Epstein-Barr nuclear antigen 1-EBNA1) variants and clinical parameters of RA patients. This prospective cohort study included 133 RA patients and 50 healthy controls. Active/recent EBV infection was more prevalent in RA patients than in controls (42% vs. 16%, p < 0.001). RA patients had higher titers of anti-EBV-CA-IgM (capsid antigen-CA) and anti-EBV-EA(D)-IgG (early antigen-EA) antibodies than controls ( p = 0.003 and p = 0.023, respectively). Lower levels of anti-EBNA1-IgG and anti-EBV-CA-IgG were observed in RA patients who received methotrexate (anti-EBNA1 IgG p < 0.001; anti-EBV-CA IgG p < 0.001). Based on amino acid residue on position 487, two EBNA1 prototypes were detected: P-Thr and P-Ala. Patients with active/recent EBV infection had a five times more chance of having RA and a nearly six times more chance of getting RA. Also, EBV active/recent infection is twice more likely in newly diagnosed than in methotrexate-treated patients. Further studies are needed to clarify "who is the chicken and who is the egg" in this EBV-RA relationship.
- Published
- 2023
- Full Text
- View/download PDF
48. Editorial: The role of novel hepatitis B biomarkers in solving therapeutic dilemmas.
- Author
-
Lazarevic I, Svicher V, and Cupic M
- Abstract
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
49. Correction to: The choroid plexus acts as an immune cell reservoir and brain entry site in experimental autoimmune encephalomyelitis.
- Author
-
Lazarevic I, Soldati S, Mapunda JA, Rudolph H, Rosito M, de Oliveira AC, Enzmann G, Nishihara H, Ishikawa H, Tenenbaum T, Schroten H, and Engelhardt B
- Published
- 2023
- Full Text
- View/download PDF
50. Association of IL10RA , IL10RB , and IL22RA Polymorphisms/Haplotypes with Susceptibility to and Clinical Manifestations of SLE.
- Author
-
Grk M, Miskovic R, Jeremic I, Basaric M, Dusanovic Pjevic M, Jekic B, Miljanovic D, Lazarevic I, Despotovic A, Cirkovic A, and Banko A
- Subjects
- Humans, Case-Control Studies, Gene Frequency, Genetic Predisposition to Disease, Genotype, Haplotypes, Hashimoto Disease complications, Polymorphism, Single Nucleotide, Interleukin-10 Receptor alpha Subunit genetics, Interleukin-10 Receptor beta Subunit genetics, Lupus Erythematosus, Systemic complications, Lupus Erythematosus, Systemic genetics
- Abstract
Systemic lupus erythematosus (SLE) is characterized by an imbalance between proinflammatory and anti-inflammatory mediators. Single-nucleotide polymorphisms (SNPs) in genes coding IL10RA , IL10RB , and IL22RA could affect their expression or function and disrupt immune homeostasis. We aimed to analyze the associations of IL10RA , IL10RB , and IL22RA polymorphisms/haplotypes with patients' susceptibility to and clinical manifestations of SLE. Our study included 103 SLE patients and 99 healthy controls. The genotypes of the selected polymorphisms within IL10RA (rs10892202, rs4252270, rs3135932, rs2228055, rs2229113, and rs9610), IL10RB (rs999788, rs2834167, and rs1058867), and IL22RA (rs3795299 and rs16829204) genes were determined by TaqMan
® Assays. IL10RB rs1058867 G allele carriers were significantly more frequent among the controls than among the SLE patients (76.8% vs. 61.2%; p = 0.017, OR = 0.477, 95% CI: 0.258-0.879). The IL10RB CAA haplotype was more frequent among the SLE patients than in the control group (42.7% vs. 30.7%; p = 0.027). The IL22RA rs3795299 C allele and rs16829204 CC genotype were associated with Hashimoto thyroiditis in the SLE patients (n = 103; p = 0.002 and p = 0.026, respectively), and in all the included participants (n = 202, p < 0.000 and p = 0.007, respectively), and the IL22RA CC haplotype was more frequent in the SLE patients with Hashimoto thyroiditis ( p = 0.047) and in the overall participants with Hashimoto thyroiditis (n = 32, p = 0.004). The IL10RA , IL10RB , and IL22RA polymorphisms/haplotypes could be associated with SLE susceptibility and various clinical manifestations, and the IL22RA CC haplotype could be associated with Hashimoto thyroiditis.- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.